Category | Data elements |
---|---|
Patients’ demographics | Age, sex, ethnicity, current address, phone number, education, occupation, and marriage status |
Medical histories | History of hypertension, dyslipidemia, DM, peripheral vascular disease, cerebrovascular disease, tumor, CKD, post PCI/CABG, post MI, mental disease; cigarette smoking; drinking and family history |
SAQ questionnaire | 19-item SAQ questionnaire, including angina frequency, physical limitations, angina stability, treatment satisfaction, and quality of life |
Depression and anxiety assessment | PHQ-9 and GAD-7 |
Admission | Admission time; symptoms, admission SBP/DBP, weight, height, HR; diagnostic; cardiac function classification; ECG findings; BMI |
Medications | Aspirin; clopidogrel; ticagrelor; statins; ezetimibe; other lipid-lowering drugs; β-blockers; CCB; ACEI/ARB; nitrates; diuretics; hypoglycemic agents |
Laboratory results | Routine blood tests; platelet function tests; glucose; HBA1c; creatinine; troponin; CK-MB; BNP; hsCRP; LDL-C; LVEF assessment by UCG |
Coronary angiography | CAG time; PCI/CABG; number of vascular lesions; LM lesion; SYNTAX score |
Mental stress test | SBP, DBP, HR and RPP at rest and 1-5Â min during mental stress |
SPECT imaging results | TPD, EDV, ESV, and EF at rest and mental stress. |
Endothelial function test | RHI |
Follow-up questionnaires | SAQ, PHQ-9 and GAD-7 questionnaire; medications; |
Clinical events | All-cause death, cardiac death, any MI, stroke, or any unplanned revascularization |